COVIDSeq Test
Diagnostic TestThe COVIDSeq is designed to test RNA extracted from NP swab specimens from patients symptomatic for COVID-19
NCT Number: NCT04561089
"This is a prospective, multi-center specimen collection study. Subjects 18 years of age or older who do not have symptoms of COVID-19 will be enrolled. Two nasal swab samples and one saliva sample will be collected from each subject. The saliva sample will be tested with the COVIDSeq Test and one nasal swab will be tested with an EUA approved COVID test. The other nasal swab sample will be stored and a subset (approximately 250 specimens) will be tested with the COVIDSeq Test. Results of all testing will be provided to the sponsor for statistical analysis.
Positive results from COVIDSeq Test using saliva and/or the comparator EUA test will be provided to subjects so participants can be referred for further evaluation (outside the study). No medical treatment, guidance on treatment decisions, nor medical care will be provided. "
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Illumina Laboratory Services, Foster City, California, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Subject Inclusion Criteria:
An individual must meet the criteria below to be eligible.
Subject Exclusion Criteria:
An individual cannot meet the below criteria.
The COVIDSeq is designed to test RNA extracted from NP swab specimens from patients symptomatic for COVID-19
Time frame: 1 month
Illumina, Inc.
Industry
Evaluation of the COVIDSeq Test in Saliva Specimens From Illumina Personnel
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07720596
COVID-19, Coronaviridae Infections
Prague, Czechia
View Trial DetailsNCT06743334
COVID-19, Coronaviridae Infections
Seoul, South Korea
View Trial DetailsNCT05876377
COVID-19, Chronic Disease
New York, United States
View Trial DetailsNCT04337424
SARS-CoV-2
Montpellier, France
View Trial Details